Orgenesis Inc. ( ORGS) - Stock Earnings
ORGS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 17, 2026, midnight | — / — | — | — / — | — |
ORGS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -34.4 million USD | -13.6 million USD |
| 2024Q1 | -9.8 million USD | 141000 USD |
| 2024Q2 | -8.9 million USD | 246000 USD |
ORGS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -18.1 million USD | 35.5 million USD |
| 2022 | -12.2 million USD | 36.0 million USD |
| 2023 | -55.4 million USD | 530000 USD |
| 2024 Est. | — | — |
ORGS
Price: $0.35
52 week price:
Earnings Per Share: -24.46 USD
P/E Ratio: -0.02
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23800
Market Capitalization: 1.8 million